EXPRESSION OF INTEREST: MSCA-PF 2026 - CINBIO (Universidade de Vigo, Spain)

EXPRESSION OF INTEREST: MSCA-PF 2026 - CINBIO (Universidade de Vigo, Spain)

EXPRESSION OF INTEREST: MSCA-PF 2026 - CINBIO (Universidade de Vigo, Spain)

• Start date: publication date
• End date: 30/06/2026

CINBIO (Universidade de Vigo, Spain) invites excellent postdoctoral researchers to submit an Expression of Interest and develop a Marie Skłodowska-Curie Postdoctoral Fellowship 2026 proposal in interdisciplinary areas at the interface of Nanomaterials and Biomedicine. The aim is to foster innovative projects addressing key challenges in health, biotechnology, and advanced materials, combining experimental and computational approaches.

Research topics span precision oncology, multi-omics and next generation therapeutics, computational and AI-driven biomedical research, systems biology, neuroscience and global health, as well as advanced nanomaterials including photonic, plasmonic, semiconductor, magnetic and catalytic systems, nano–bio interactions, biomolecular interfaces, and smart and functional materials. Proposals may address cancer biology, personalised medicine, rare and infectious diseases, advanced therapies and diagnostics, sustainable chemistry, and bioanalytical applications.

CINBIO provides access to more than 30 laboratories and core facilities for bioexperimentation, nanomaterial synthesis, sample preparation and advanced characterisation (including microscopy, flow cytometry, molecular biology, spectroscopy and nanofabrication), as well as HPC clusters, NGS and 10X platforms, and clinical resources through CACTI and regional hospitals and biobanks.

The project will benefit from high-quality supervision aligned with MSCA guidance, involving leading researchers across CINBIO groups, and an excellent training environment through courses, workshops, seminars and hands-on training.

List of research areas and supervisors:

• EOI 1-MSCA-PF 2026-Precision Oncology. Focus on cancer biology, immunotherapy, tumour heterogeneity and treatment response through immunology, cancer cell communication and computational genomics. Supervisors include África González, María Mayán and David Posada.
• EOI 2-MSCA-PF 2026-Multiomics and Next Generation Therapeutics. Focus on translating multiomic data into diagnostics and personalised treatments, including rare diseases, mRNA therapies and single-cell approaches. Supervisors include África González, María Mayán, David Posada and Diana Valverde.
• EOI 3-MSCA-PF 2026– Computational and AI-driven Biomedical Research. Focus on AI-based prediction, disease progression and treatment response using biomedical data. Supervisors include David Posada and Diana Valverde.
• EOI 4-MSCA-PF 2026– Systems Biology, Neuroscience and Global Health. Focus on biological systems, neurological disorders, infectious diseases, antiviral strategies and One Health approaches. Supervisors include África González, Ángel Rodríguez de Lera, Ana Gago, Juan Pérez and Miguel Arenas.
• EOI 5-MSCA-PF 2026-Advanced Photonic, Plasmonic and Semiconductor Nanomaterials. Focus on the design of nanomaterials with tailored optical properties for technological and biomedical applications, including biosensing and bioimaging. Supervisors include Isabel Pastoriza, Luis Liz, Miguel Correa and Laksminarayana Polavarapu.
• EOI 6-MSCA-PF 2026– Advanced Magnetic and Catalytic Nanomaterials. Focus on functional nanomaterials for environmental, energy and biological applications, including catalysis and magnetic nanoparticles. Supervisors include Verónica Salgueiriño and Miguel Correa.
• EOI 7-MSCA-PF 2026– Nano–bio Interactions and Biomolecular Interfaces. Focus on interactions between nanomaterials and biological systems, biofunctionalisation and nanobiohybrid materials. Supervisors include Isabel Pastoriza and Luis Liz.
• EOI 8-MSCA-PF 2026– Smart, Responsive and Chiral Functional (Nano)materials and Biomaterials. Focus on advanced materials with controlled structure and responsiveness, including chiral systems, supramolecular materials and sustainable biomaterials. Supervisors include Isabel Pastoriza, Luis Liz, Herminia Domínguez and Félix Freire.

The HORIZON-MSCA-2026-PF-01 call is open from 09/04/2026 to 09/09/2026; applicants must hold a PhD (or four years’ equivalent research experience), comply with MSCA mobility rules and have up to eight years of research experience from the PhD award date (more info).

If you are interested in working with us, send, by 30/06/2026, a CV, brief project summary and motivation letter to cinbio.eup@uvigo.es.

For further support in the MSCA-PF application do not hesitate to contact either the UVigo (opi.promo@uvigo.gal) or CINBIO (cinbio.eup@uvigo.es) project office. For more specific scientific questions directly contact the PIs.